Caprock »

Aktis Oncology shares owned by Caprock

Quarter-by-quarter ownership of Aktis Oncology (AKTS) shares owned by Caprock from 13F filings

Historical chart of Caprock investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Caprock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Caprock

Quarter filed Position value Share count Share price at filing
2026-06-30 $319k 9.9k 32.23

More positions owned by Caprock

Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Sentinelone Cl A (S)
Liquidia Corporation Com New (LQDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Equity Lifestyle Properties (ELS)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)

View all positions for Caprock

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
Blue Owl Capital Holdings
BlackRock
Wellington Management Company
Rtw Investments
T. Rowe Price Associates
Henderson Group
RA Capital Management
Jupiter Topco
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
TCG Crossover Management

View all funds holding Aktis Oncology